Shares of Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) have been given a consensus rating of "Moderate Buy" by the eleven ratings firms that are covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $21.4545.
Several brokerages have recently issued reports on DOC. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and issued a $18.00 price objective (down previously from $28.00) on shares of Healthpeak Properties in a research note on Wednesday, August 20th. Raymond James Financial raised shares of Healthpeak Properties from a "market perform" rating to an "outperform" rating and set a $20.00 target price on the stock in a research report on Monday, September 15th. Robert W. Baird set a $21.00 target price on shares of Healthpeak Properties and gave the stock an "outperform" rating in a research report on Wednesday, July 30th. Wells Fargo & Company dropped their target price on shares of Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating on the stock in a research report on Wednesday, August 27th. Finally, Morgan Stanley dropped their target price on shares of Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating on the stock in a research report on Friday, August 22nd.
Get Our Latest Stock Report on DOC
Insider Buying and Selling at Healthpeak Properties
In other news, CEO Scott M. Brinker bought 2,930 shares of the company's stock in a transaction dated Thursday, July 31st. The shares were acquired at an average cost of $17.06 per share, with a total value of $49,985.80. Following the completion of the transaction, the chief executive officer directly owned 210,416 shares in the company, valued at approximately $3,589,696.96. The trade was a 1.41% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders have purchased 8,783 shares of company stock valued at $150,129 over the last quarter. Company insiders own 0.23% of the company's stock.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Fifth Third Wealth Advisors LLC grew its position in Healthpeak Properties by 2.4% during the second quarter. Fifth Third Wealth Advisors LLC now owns 22,811 shares of the real estate investment trust's stock valued at $399,000 after purchasing an additional 543 shares in the last quarter. Parallel Advisors LLC lifted its stake in Healthpeak Properties by 4.2% in the first quarter. Parallel Advisors LLC now owns 13,980 shares of the real estate investment trust's stock valued at $283,000 after acquiring an additional 561 shares during the last quarter. Applied Finance Capital Management LLC lifted its stake in Healthpeak Properties by 3.4% in the first quarter. Applied Finance Capital Management LLC now owns 17,648 shares of the real estate investment trust's stock valued at $357,000 after acquiring an additional 577 shares during the last quarter. AssuredPartners Investment Advisors LLC lifted its stake in Healthpeak Properties by 3.1% in the first quarter. AssuredPartners Investment Advisors LLC now owns 22,088 shares of the real estate investment trust's stock valued at $447,000 after acquiring an additional 666 shares during the last quarter. Finally, LRI Investments LLC lifted its stake in shares of Healthpeak Properties by 18.4% in the second quarter. LRI Investments LLC now owns 4,481 shares of the real estate investment trust's stock worth $78,000 after buying an additional 697 shares during the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.
Healthpeak Properties Price Performance
Shares of DOC traded down $0.09 during mid-day trading on Friday, hitting $18.48. The company's stock had a trading volume of 18,092,242 shares, compared to its average volume of 5,921,982. The firm has a 50-day moving average price of $17.76 and a 200 day moving average price of $18.11. The stock has a market capitalization of $12.84 billion, a price-to-earnings ratio of 77.00, a PEG ratio of 2.38 and a beta of 1.07. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.28. Healthpeak Properties has a fifty-two week low of $16.63 and a fifty-two week high of $23.26.
Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.46. The company had revenue of $694.35 million for the quarter, compared to analysts' expectations of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The business's revenue was down .2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, research analysts predict that Healthpeak Properties will post 1.86 EPS for the current fiscal year.
Healthpeak Properties Dividend Announcement
The company also recently announced a monthly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 18th were given a $0.1017 dividend. This represents a c) annualized dividend and a dividend yield of 6.6%. The ex-dividend date of this dividend was Monday, August 18th. Healthpeak Properties's dividend payout ratio (DPR) is 508.33%.
Healthpeak Properties Company Profile
(
Get Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.